1.
A lack of delayed intraocular pressure elevation in patients treated with intravitreal injection of bevacizumab and ranibizumab.
Wehrli Sarah J, Tawse Kirstin, Levin Marc H, Zaidi Ali, Pistilli Maxwell, Brucker Alexander J
RetinaJul 201266 citationsRetrospective Chart Review
This study found anti-VEGF injections for AMD did not significantly increase delayed IOP elevation risk in injected eyes compared to control eyes, including those with glaucoma, suggesting low long-term IOP risk.